Qu Biologics Inc.
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infection in Older Adults (NCT05421325) | Qu Biologics Inc. | 2023-04-11 |
| QBECO SSI for Clinical and Endoscopic Remission in Moderate to Severe Crohn's Disease (NCT03472690) | Qu Biologics Inc. | 2018-06-25 |
| Single and Multiple Dose Evaluation of QBKPN SSI In Healthy Volunteers (NCT02897999) | Qu Biologics Inc. | 2016-09-01 |
| Safety and Efficacy of QBECO in Moderate to Severe Ulcerative Colitis (NCT02426372) | Qu Biologics Inc. | 2015-07-01 |
| Exploratory Study of QBKPN SSI in Non-Small Cell Lung Cancer (NCT02256852) | Qu Biologics Inc. | 2014-12-01 |
| Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's Disease (NCT01809275) | Qu Biologics Inc. | 2013-03-01 |
Track Qu Biologics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.